Internal Medicine, Gastroenterology · Cleveland, OH
NPI
1912299553
Since 2011
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
9500 Euclid Ave
Cleveland, OH, 44195
Phone (216) 444-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
364 services
Medicare patients, 2024
160
Average age 68
Drug cost, 2024
$2.3M
400 prescriptions
Company payments, 2025
$124K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Taha M Qazi was code 99214 (office e&m - established), 55 times for 37 patients. In total Taha M Qazi billed 364 services in 33 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 55 | 37 | $83.89 | $4,614 |
| 99214 Office E&M - Established | Facility | 54 | 38 | $61.46 | $3,319 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 52 | 40 | $12.45 | $648 |
| 45380 Lower GI Endoscopy - Other | Facility | 33 | 32 | $126.15 | $4,163 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 22 | 21 | $12.49 | $275 |
| 43235 Upper GI Endoscopy | Facility | 16 | 16 | $80.11 | $1,282 |
| 43239 Upper GI Endoscopy | Facility | 15 | 15 | $63.80 | $957 |
| 99204 Office E&M - New | Facility | 14 | 14 | $93.84 | $1,314 |
| 44386 Digestive/Gastrointestinal | Facility | 14 | 14 | $62.22 | $871 |
| 99233 Hospital E&M - Subsequent | Facility | 14 | 14 | $88.58 | $1,240 |
By year: 2022 $26K for 330 services; 2023 $23K for 277 services; 2024 $26K for 364 services.
Medicare prescription drug claims, 2024
In 2024, the drug Taha M Qazi prescribed most often to Medicare patients was Skyrizi On-Body (Risankizumab-Rzaa), with 57 prescriptions and refills. In total Taha M Qazi wrote 400 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Skyrizi On-Body Risankizumab-Rzaa | 57 | 101 | 12 | $1.1M |
| Stelara Ustekinumab | 31 | 42 | Under 11 | $896K |
| Balsalazide Disodium Generic | 22 | 24 | Under 11 | $1,877 |
| Mesalamine Generic | 21 | 25 | Under 11 | $3,372 |
| Vancomycin Hcl Generic | 15 | 15 | Under 11 | $7,683 |
| Amitriptyline Hcl Generic | 14 | 19 | Under 11 | $92.97 |
| Entyvio Vedolizumab | 14 | 14 | Under 11 | $108K |
| Methotrexate Methotrexate Sodium | 13 | 18 | Under 11 | $341 |
| Sucralfate Generic | 13 | 13 | Under 11 | $259 |
| Loperamide Loperamide Hcl | 12 | 20 | Under 11 | $262 |
| Colestipol Hcl Generic | 11 | 27 | Under 11 | $883 |
| Metronidazole Generic | 11 | 11 | Under 11 | $134 |
Brand drugs: 166 claims; generic drugs: 234 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Taha M Qazi $124K ($124K in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $77K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.